Opendata, web and dolomites
H2020 projects about "cytotoxic"
The page lists 67 projects related to the topic "cytotoxic".
| # | |||
|---|---|---|---|
| 1 | PROCROP | Professional cross-priming for ovary and prostate cancer | 2015 |
| 2 | Autophagy in vitro | Reconstituting Autophagosome Biogenesis in vitro | 2015 |
| 3 | DNAendProtection | DNA end protection in Immunity and Cancer | 2015 |
| 4 | MAGICBULLET | Peptide-Drug Conjugates for Targeted Delivery in Tumor Therapy | 2015 |
| 5 | BioGuidePCa | Biomarker Guided Prostate Cancer Management | 2014 |
| 6 | Pharmcophore-DOS | Pharmacophore guided diversity-oriented synthesis and its application in discovering inhibitors of protein-protein interactions between RAD51 and BRCA2 | 2015 |
| 7 | Leucophyl | Total Synthesis of Leucophyllidine | 2015 |
| 8 | KSHV QTV | Identification of novel KSHV immune evasion mechanisms using a quantitative temporal viromics analysis | 2015 |
| 9 | AuNP-PhotoBioDrug | Functionalized AuNPs and their use for biological applications | 2015 |
| 10 | ChemoBOOM | Development of Palladium-Labile Prodrugs for Bioorthogonally-Activated Chemotherapy | 2016 |
| 11 | LABVaccFish | USE OF LACTIC ACID BACTERIA AS DELIVERY VEHICLE FOR ORAL VACCINATION OF FISH | 2016 |
| 12 | PREVENT | Prostate cancer extracellular vesicles as biomarkers for nanomedicine treatment | 2015 |
| 13 | ZAUBERKUGEL | Fulfilling Paul Ehrlich’s Dream: therapeutics with activity on demand | 2015 |
| 14 | CholangioConcept | Functional in vivo analysis of cholangiocarcinoma development, progression and metastasis. | 2015 |
| 15 | M-Imm | Novel etiology of autoimmune disorders: the role of acquired somatic mutations in lymphoid cells | 2015 |
| 16 | SYNECT | Immunological synapse derived ectosomes in T cell effector function | 2015 |
| 17 | LDC4PCaTher | BMX-targeted ligand-drug conjugates for prostate cancer therapy | 2016 |
| 18 | HALO | Understanding Halophytes for an Agriculture Worth its Salt | 2016 |
| 19 | NanoBioCar | Impacts of Nanoparticles on microphytobenthic Biofilms and consequences on the Carbon cycle | 2016 |
| 20 | DynOMIS | Dynamic Origins of MHC class I Selector function | 2016 |
| 21 | SLIM | Synthetic Lethal Interactions with nucleophosMin 1 | 2016 |
| 22 | GLUTORHIV | Glucose metabolism and mTOR pathway role in CD8+ T cell control of HIV-1 | 2016 |
| 23 | BiominAB-3D | Revealing the composition and formation mechanism of carcinogenic asbestos bodies in human lungs | 2016 |
| 24 | FLUORODRUGS | Smart Theranostic Agents for the Tumour Microenvironment | 2017 |
| 25 | Neurotoxic | An Ultra-sensitive Assay to Measure Oligomer Induced Toxicity in Human Cerebrospinal Fluid | 2016 |
| 26 | CoBABATI | Cofactor Binding Antibodies – Basic Aspects and Therapeutic Innovations | 2016 |
| 27 | CDK6-DrugOpp | CDK6 in transcription - turning a foe in a friend | 2016 |
| 28 | TILC | Targeting Innate Lymphoid Cells | 2017 |
| 29 | SUMCASTEC | Semiconductor-based Ultrawideband Micromanipulation of CAncer STEm Cells | 2017 |
| 30 | IMMUNOSABR | Clinical proof of concept through a randomised phase II study: a combination of immunotherapy and stereotactic ablative radiotherapy as a curative treatment for limited metastatic lung cancer | 2017 |
| 31 | MONONANOCHEM | In vivo engineering of monocytes loaded with nano-chemotherapeutic formulations: a novel live-cell mediated drug delivery system for the treatment of cancer | 2017 |
| 32 | Curtana | Patented small molecule therapeutics that target cancer stem cells for the treatment of glioblastoma and other brain cancers | 2017 |
| 33 | TRPLigDrugConj | TRPV1-targeted ligand-drug conjugates to treat prostate cancer | 2017 |
| 34 | ChroSoDSB | Chromatin Study of DNA Double Strand Breaks | 2017 |
| 35 | GlycoNanoPep | Glyco and Nano Peptide Conjugates for Selective Cell Penetration | 2017 |
| 36 | NanoALS | Nanoparticle-based immunization, a novel therapeutic strategy for amyotrophic lateral sclerosis | 2018 |
| 37 | SOMBOT | Soft Micro Robotics | 2017 |
| 38 | TRIPLECON | Triple negative breast cancer control through synergistic inhibition of EGFR and CDK9 signaling | 2017 |
| 39 | ImmunoFit | Harnessing tumor metabolism to overcome immunosupression | 2018 |
| 40 | InflamCellDeath | Mechanism and function of gasdermin-induced inflammatory cell death | 2018 |
| 41 | ToCCaTa | Tailoring the functional Capacity of Cytotoxic T cells for future Therapies | 2018 |
| 42 | CL_Exocytosis | “Molecular dissection of cytotoxic lymphocyte exocytosis | 2019 |
| 43 | ELECTRO NEEDLE | In situ stem cell monitoring system based on conductive nanoneedle devices for tracking cell fates in invasive manner | 2018 |
| 44 | HifLICs | Acute Myeloid Leukemia Leukemic Initiating Cells: Contribution of hypoxia/HIF pathway to chemoresistance and relapse | 2019 |
| 45 | Tracer-T | Analysis of the effect of the tumour microenvironment on T cell functional phenotype | 2018 |
| 46 | NANOBOTS | Tumor-Targeting Nanoengineered Bioorthogonal Technologies to Fight Metastatic Cancers | 2018 |
| 47 | EditMHC | How MHC-I editing complexes shape the hierarchical immune response | 2019 |
| 48 | FOCALISE | Facile Oxygen Consumption Assay for Lacteal Industry and Spoilage Evaluation | 2018 |
| 49 | SkinTrmDeep | Tissue Resident Memory (Trm) CD8+ T cells: Genome-wide dissection of cellular differentiation and heterogeneity | 2019 |
| 50 | ImmunoCode | Digital Single Cell Immunology: Decoding Cellular Interactions for Improved Immunotherapy | 2018 |
| 51 | LUMAX | Innovative Laser and Fiber System for Non-Toxic, Efficient and Cost-Effective Treatment of Cancer | 2018 |
| 52 | PRinTERs | Post-transcriptional regulation of effector function in T cells by RNA binding proteins | 2019 |
| 53 | Biosensor Design | Engineering Chemotactic Biosensors for a Diverse Spectrum of Metastatic Markers | 2020 |
| 54 | MHT-ImmunoEnhancer | Stimuli-Responsive Nanoplatform to Combine Magnetic Hyperthermia with Immunemodulators Delivery for Glioblastoma Treatment | 2019 |
| 55 | Inflapoptosis | Gasdermin D is a novel effector in the extrinsic apoptosis pathway | 2019 |
| 56 | ELECTROSULF | Electrochemical Sulfonylation of Lysine Residues in Continuous Flow Microreactors. | 2019 |
| 57 | TUBE | Transport derived Ultrafines and the Brain Effects | 2019 |
| 58 | CAN-IT-BARRIERS | Disruption of systemic and microenvironmental barriers to immunotherapy of antigenic tumors | 2020 |
| 59 | ARTimmune | Programmable ARTificial immune systems to fight cancer | 2019 |
| 60 | TAcTIC | TArgeTed molecular Imaging and surgery for gastro-intestinal Cancer | 2019 |
| 61 | LIGHT4LUNGS | Inhalable Aerosol Light Source for Controlling Drug-Resistant Bacterial Lung Infections | 2019 |
| 62 | Bio-TUNE | Fine tune of cellular behavior: multifunctional materials for medical implants | 2020 |
| 63 | TACT | Targeted Anti-Cancer Therapies | 2020 |
| 64 | KineTic | New Reagents for Quantifying the Routing and Kinetics of T-cell Activation | 2020 |
| 65 | Ru4EYE | Ruthenium-based photoactivated chemotherapy against eye cancer | 2020 |
| 66 | DREAM | Dux4-Regulated Expression and Activity by MATR3 | 2020 |
| 67 | RASATaC | Regulating RAS Activity to Target RAS-Driven Cancers | 2020 |